← Leaderboards
Abraham Kovoor
Kovogen
$1,542,304
Attributed
$1,542,304
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $475.8K · FY2006–11$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,542,304 · 8
By mechanism
P20$667,571 · 6
R41$507,148 · 1
R15$367,585 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Abnormal Involuntary Movement”
- Un Jung Kang · University Of Chicago$5,542,592
- David Eidelberg · North Shore University Hospital$5,397,117
- Hyder A Jinnah · Johns Hopkins University$5,357,482
- Julius P Dewald · Rehabilitation Institute Of Chicago$5,173,863
- Caroline M. Tanner · Parkinson'S Institute$4,579,868
- Kristina Simonyan · Massachusetts Eye And Ear Infirmary$3,836,139
Research focus
Abnormal Involuntary MovementCorpus Striatum StructureParkinson DiseasePharmacotherapyPharmaceutical PreparationsTardive DyskinesiaSchizophreniaAntipsychotic AgentsSignal PathwayDyskinetic SyndromeFundingFamilySourceNeuronsMovementSignal TransductionResourcesDopamine D2 ReceptorMediatingChronicBasal GangliaGrantGenesUnited States National Institutes Of Health
Grant awards (10)
ROLE OF THE STRIATAL-SPECIFIC RGS PROTEIN RGS9-2, IN CELLULAR SIGNALING PATHWAYS$86,612
P20 · FY2011 · RR · contact PI
Development of A Novel Animal Model of Tardive Dyskinesia$367,585
R15 · FY2010 · MH · contact PI
ROLE OF THE STRIATAL-SPECIFIC RGS PROTEIN RGS9-2, IN CELLULAR SIGNALING PATHWAYS$93,313
P20 · FY2010 · RR · contact PI
MODULATION OF D2-LIKE DOPAMINE RECEPTOR-MEDIATED STRIATAL SIGNALING PATHWAYS BY$187,121
P20 · FY2009 · RR · contact PI
MODULATION OF D2-LIKE DOPAMINE RECEPTOR-MEDIATED STRIATAL SIGNALING PATHWAYS BY$186,642
P20 · FY2008 · RR · contact PI
EMBRYONIC MOUSE STEM CELLS REPAIR BRAIN TOXICITY CAUSED BY ANTIPSYCHOTIC DRUGS$15,097
P20 · FY2008 · RR · contact PI
A Genetic Test for Drug-Induced Dyskinesia Risk Determination$251,770
R41 · FY2007 · MH · contact PI
A Genetic Test for Drug-Induced Dyskinesia Risk Determination$125,231
R41 · FY2007 · MH · contact PI
MODULATION OF D2-LIKE DOPAMINE RECEPTOR-MEDIATED STRIATAL SIGNALING PATHWAYS BY$98,786
P20 · FY2007 · RR · contact PI
A Genetic Test for Drug-Induced Dyskinesia Risk$130,147
R41 · FY2006 · MH · contact PI